Hypercalcemia of Malignancy /
Hypercalcemia is the most common life-threatening metabolic disorder associated with cancer. The pathophysiological, epidemiological and clinical aspects of hypercalcemia of malignancy are presented in this issue, with a focus on the recently discovered humoral factor responsible for the development...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
1994.
|
| Series: | Recent results in cancer research ;
137. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Hypercalcemia is the most common life-threatening metabolic disorder associated with cancer. The pathophysiological, epidemiological and clinical aspects of hypercalcemia of malignancy are presented in this issue, with a focus on the recently discovered humoral factor responsible for the development of hypercalcemia. With a better understanding of the pathophysiology of this condition and the development of new potent drugs, capable of inhibiting bone resorption, especially bisphosphonates, the clinician will be more successful in correcting hypercalcemia in the great majority of patients. |
|---|---|
| Item Description: | Electronic resource. |
| Physical Description: | 1 online resource (vii, 163 pages 25 illustrations) |
| ISBN: | 9783642850738 (electronic bk.) 3642850731 (electronic bk.) |
| ISSN: | 0080-0015 ; |